While total laboratory automation has permanently altered the analytical phase of clinical laboratory work, the front-end collection process has remained a stubbornly manual, labor-intensive bottleneck. However, that may be about to change, based on early signs. Vitestro recently announced an over-subscribed $70 million Series B funding round to accelerate operational scaling and commercial readiness for […]
Major Players Back Robotic Phlebotomy with $70M
Vitestro’s Series B funding signals a shift toward automating the pre-analytical workflow
- By Janette Wider
- > From the Volume XXXIII, No. 4 - March 23, 2026 Issue
- Tags: ADOPT study, ADOPT trial, Advocate Health, Aletta Autonomous Robotic Phlebotomy Device, ARPD, Bob Bergerich, CE mark, EIC Fund, FDA, Fred Moll, Intermountain Health, InterVest, Intuitive Surgical, Invest-NL, Labcorp Venture Fund, laboratory automation, Mayo Clinic, Medical University of South Carolina, MGFO, North American Journal of Medical Sciences, Northwestern Medicine, NYBC Ventures, PGGM, pre-analytical workflow, Puma Venture Capital, robotic phlebotomy, robotic venipuncture, ROM Utrecht, Sonder Capital, Sutter Health, Toon Overbeeke, US Food and Drug Administration, Vitestro
